{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:41:33Z","timestamp":1789940493050,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Canadian Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["#2883"],"award-info":[{"award-number":["#2883"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jcf.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T02:48:34Z","timestamp":1462070914000},"page":"839-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity?"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-3287","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Boudreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e8le","family":"Coriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Hammana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ziai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Berthiaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2016.04.004_bb0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-2600(13)70026-2","article-title":"Early lung disease in cystic fibrosis","volume":"1","author":"Grasemann","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.jcf.2016.04.004_bb0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11892-014-0511-3","article-title":"Cystic fibrosis related diabetes","volume":"14","author":"O'Shea","year":"2014","journal-title":"Curr Diab Rep"},{"issue":"3 Pt 1","key":"10.1016\/j.jcf.2016.04.004_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1262-3636(07)70189-1","article-title":"Diabetes: a major co-morbidity of cystic fibrosis","volume":"31","author":"Costa","year":"2005","journal-title":"Diabetes Metab"},{"issue":"9","key":"10.1016\/j.jcf.2016.04.004_bb0020","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcf.2016.04.004_bb0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1590\/S0004-27302008000200006","article-title":"Cystic fibrosis-related diabetes: a frequent co-morbidity","volume":"52","author":"Della Manna","year":"2008","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.jcf.2016.04.004_bb0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jcf.2016.04.004_bb0035","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcf.2016.04.004_bb0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jcf.2009.08.007","article-title":"Validation of insulin secretion indices in cystic fibrosis patients","volume":"8","author":"Hammana","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"11","key":"10.1016\/j.jcf.2016.04.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112578","article-title":"High variability in oral glucose tolerance among 1128 patients with cystic fibrosis: a multicenter screening study","volume":"9","author":"Scheuing","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jcf.2016.04.004_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1464-5491.2002.00666.x","article-title":"Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction","volume":"19","author":"Yung","year":"2002","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.jcf.2016.04.004_bb0055","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1464-5491.2009.02738.x","article-title":"Mechanisms of glucose intolerance in cystic fibrosis","volume":"26","author":"Mohan","year":"2009","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.jcf.2016.04.004_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0026-0495(94)90239-9","article-title":"Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis","volume":"43","author":"Ahmad","year":"1994","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.jcf.2016.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/diab.43.8.1020","article-title":"Insulin sensitivity in cystic fibrosis","volume":"43","author":"Moran","year":"1994","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jcf.2016.04.004_bb0070","doi-asserted-by":"crossref","first-page":"E1022","DOI":"10.1152\/ajpendo.2001.281.5.E1022","article-title":"Mechanisms of insulin resistance in cystic fibrosis","volume":"281","author":"Hardin","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jcf.2016.04.004_bb0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","article-title":"Update on cystic fibrosis-related diabetes","volume":"12","author":"Kelly","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2016.04.004_bb0080","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jpeds.2007.05.012","article-title":"Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes","volume":"151","author":"Elder","year":"2007","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jcf.2016.04.004_bb0085","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/jc.2013-2756","article-title":"Impact of sex on insulin secretion in cystic fibrosis","volume":"99","author":"Coriati","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jcf.2016.04.004_bb0090","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc08-0466","article-title":"Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults","volume":"31","author":"Adler","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcf.2016.04.004_bb0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.dld.2015.09.010","article-title":"Bowel ultrasound imaging in patients with cystic fibrosis: relationship with clinical symptoms and CFTR genotype","volume":"48","author":"Fraquelli","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.jcf.2016.04.004_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ejhg.2008.136","article-title":"Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders\u2014updated European recommendations","volume":"17","author":"Dequeker","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2016.04.004_bb0105","first-page":"S1","article-title":"Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"37","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert C","year":"2013","journal-title":"Can J Diabetes"},{"issue":"3","key":"10.1016\/j.jcf.2016.04.004_bb0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcf.2016.04.004_bb0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcf.2010.11.004","article-title":"Validation of insulin secretion indices in cystic fibrosis","volume":"10","author":"Ziai","year":"2011","journal-title":"J. Cyst. Fibros."},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2016.04.004_bb0120","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.2337\/diabetes.51.2007.S212","article-title":"Accurate assessment of beta-cell function: the hyperbolic correction","volume":"51","author":"Bergman","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jcf.2016.04.004_bb0125","article-title":"Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET)","author":"Coriati","year":"2015","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.jcf.2016.04.004_bb0130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcf.2007.02.005","article-title":"Increased glucose excursion in cystic fibrosis and its association with a worse clinical status","volume":"6","author":"Costa","year":"2007","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.jcf.2016.04.004_bb0135","first-page":"253","article-title":"Glucose intolerance in cystic fibrosis patients","volume":"2","author":"Lanng","year":"2001","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2016.04.004_bb0140","doi-asserted-by":"crossref","DOI":"10.2337\/db14-0810","article-title":"The DeltaF508 mutation in the cystic fibrosis transmembrane conductance regulator is associated with progressive insulin resistance and decreased functional Beta-cell mass in mice","author":"Fontes","year":"2015","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jcf.2016.04.004_bb0145","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.diabet.2011.09.001","article-title":"Is it important to consider how hyperinsulinaemic\u2013euglycaemic clamp results are expressed?","volume":"37","author":"Disse","year":"2011","journal-title":"Diabetes Metab"},{"issue":"3","key":"10.1016\/j.jcf.2016.04.004_bb0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabet.2011.01.002","article-title":"How can we measure insulin sensitivity\/resistance?","volume":"37","author":"Antuna-Puente","year":"2011","journal-title":"Diabetes Metab"},{"issue":"8","key":"10.1016\/j.jcf.2016.04.004_bb0155","first-page":"1764","article-title":"Effect of physical activity on insulin resistance, inflammation and oxidative stress in diabetes mellitus","volume":"7","author":"Venkatasamy","year":"2013","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"10.1016\/j.jcf.2016.04.004_bb0160","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/17476348.2014.966693","article-title":"Cystic fibrosis and physiological responses to exercise","volume":"8","author":"Williams","year":"2014","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"10.1016\/j.jcf.2016.04.004_bb0165","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jc.2005-2135","article-title":"Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis","volume":"91","author":"Moriconi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcf.2016.04.004_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.diabres.2014.03.002","article-title":"Could T cells be involved in lung deterioration and hyperglycemia in cystic fibrosis?","volume":"105","author":"Ziai","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl. 6A","key":"10.1016\/j.jcf.2016.04.004_bb0175","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(02)01276-7","article-title":"Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities","volume":"113","author":"LeRoith","year":"2002","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.jcf.2016.04.004_bb0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cjca.2011.01.016","article-title":"Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary)","volume":"27","author":"Cardiometabolic Risk Working Group: Executive C","year":"2011","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.jcf.2016.04.004_bb0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pedi.12026","article-title":"Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study","volume":"14","author":"Bellin","year":"2013","journal-title":"Pediatr Diabetes"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316300212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316300212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T22:16:29Z","timestamp":1636064189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199316300212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1569199316300212"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2016.04.004","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}